Tong Yang Venture Capital
2
5M
2
0.06
- Stages of investment
- Areas of investment
Summary
In 1989 was created Tong Yang Venture Capital, which is appeared as VC. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Novartis Venture Fund, IDG Ventures Korea.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Manufacturing. Among the various public portfolio startups of the fund, we may underline PharmAbcine
The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2009. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.06
- Investments by industry
- Therapeutics (1)
- Biotechnology (1)
- Health Care (1)
- Semiconductor (1)
- Manufacturing (1) Show 1 more
- Investments by region
-
- South Korea (2)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| PharmAbcine | 16 Sep 2009 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 6M | Gyeonggi-do, South Korea, South Korea |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.